Schizophrenic Patients in Integrated Care

PHASE4TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Interventions
DRUG

Quetiapine XR

400-800 mg, oral, bid

OTHER

Integrated Care Program (ICP)

Integrated care program (ICP), this is a legally based integrated care program covered by a contract according to §§ 140 a-d SGB-V (SGB: social security code); The ICP is not exclusively designed for this phase IV trial. Participation in the ICP is possible anytime for each patient in whom the services are covered by the individual health insurance.

Trial Locations (8)

Unknown

Research Site, München

Research Site, Oranienburg

Research Site, Hamburg

Research Site, Lüneburg

Research Site, Oldenburg

Research Site, Chemnitz

Research Site, Berlin

Research Site, Stolberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY